Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 14 citing articles:

Prognostic Ability of Enhancer RNAs in Metastasis of Non-Small Cell Lung Cancer
Jun Liu, Jingyi Jia, Siqiao Wang, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4108-4108
Open Access | Times Cited: 43
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
Lindsey Carlsen, Kelsey E. Huntington, Wafik S. El‐Deiry
Cancers (2022) Vol. 14, Iss. 4, pp. 1028-1028
Open Access | Times Cited: 41
The role of p53 in anti-tumor immunity and response to immunotherapy
Lindsey Carlsen, Shengliang Zhang, Xiaobing Tian, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 36
Nano-curcumin formulations for targeted therapy of colorectal cancer
Hossein Shahdadi Sardou, Seyedeh Elnaz Nazari, Mohammadreza Abbaspour, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 88, pp. 104943-104943
Closed Access | Times Cited: 10
Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents
Lindsey Carlsen, Wafik S. El‐Deiry
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11828-11828
Open Access | Times Cited: 22
An Overview of Heavy Chain Ferritin in Cancer
Xiaoyan Shi, Anqi Zhang, Jinzhi Lu, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 8, pp. 182-182
Open Access | Times Cited: 8
Optimal administration strategy in chemotherapy regimens using multi-drug cell-cycle specific tumor growth models
Parak Qods, Jamal Arkat, Yazdan Batmani
Biomedical Signal Processing and Control (2023) Vol. 86, pp. 105221-105221
Closed Access | Times Cited: 4
Unlocking the Potential of Therapy-Induced Cytokine Responses: Illuminating New Pathways in Cancer Precision Medicine
Dilip Reddy Gunturu, Md. Imtaiyaz Hassan, Deepa Bedi, et al.
Current Oncology (2024) Vol. 31, Iss. 3, pp. 1195-1206
Open Access | Times Cited: 1
Temozolomide combined with ipilimumab plus nivolumab enhances T cell killing of MGMT-expressing, MSS colorectal cancer cells.
Zenovia Gonzalez, Lindsey Carlsen, Wafik S. El‐Deiry
PubMed (2023) Vol. 13, Iss. 1, pp. 216-226
Closed Access | Times Cited: 3
Chemotherapy-induced cytokines and prognostic gene signatures vary across breast and colorectal cancer.
Leya Groysman, Lindsey Carlsen, Kelsey E. Huntington, et al.
PubMed (2021) Vol. 11, Iss. 12, pp. 6086-6106
Closed Access | Times Cited: 7
Patient-derived Organoid Model for Predicting the Chemoresponse in Patients With Colorectal Cancer
KIYOUN YI, SUNG HEE PARK, D. Kim, et al.
In Vivo (2023) Vol. 37, Iss. 4, pp. 1751-1759
Open Access | Times Cited: 2
Unlocking the Potential of Therapy-Induced Cytokine Responses: Illuminating New Pathways in Cancer Precision Medicine
Dilip Reddy Gunturu, Md. Imtaiyaz Hassan, Deepa Bedi, et al.
(2023)
Open Access | Times Cited: 1
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers
Lindsey Carlsen, Kelsey E. Huntington, Wafik S. El‐Deiry
(2021)
Open Access
Page 1

Scroll to top